SEARCH

SEARCH BY CITATION

References

  • Bailey, S.J. & Hourani, S.M.O. (1994). Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol., 112, 219225.
  • Bailey, S.J. & Hourani, S.M.O. (1995). Effects of suramin on contractions of the guinea-pig vas deferens induced by analogues of adenosine 5′-triphosphate. Br. J. Pharmacol., 114, 11251132.
  • Burnstock, G. & King, B.F. (1996). The numbering of cloned P2 purinoceptors. Drug Dev. Res., 38, 6771.
  • Busse, R., Ogilvie, A. & Pohl, U. (1988). Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries. Am. J. Physiol., 254, H828H832.
  • Castillo, C.J.F., Moro, M.A., Del Valle, M., Sillero, A., García, A.G. & Sillero, M.A.G. (1992). Diadenosine tetraphosphate is coreleased with ATP and catecholamines from bovine adrenal medulla. J. Neurochem., 59, 723732.
  • Castro, E., Pintor, J. & Miras-Portugal, M.T. (1992). Ca2+-stores mobilization by adenosine tetraphosphate, Ap4A, through a putative P2Y purinoceptor in adrenal chromaffin cells. Br. J. Pharmacol., 106, 833837.
  • Charlton, S.J., Brown, C.A., Weisman, G.A., Turner, J.T., Erb, L. & Boarder, M.J. (1996). PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br. J. Pharmacol., 118, 704710.
  • Collo, G., North, R.A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A. & Buell, G. (1996). Cloning of the P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci., 16, 24952507.
  • Crack, B.E., Pollard, C.E., Beukers, M.W., Roberts, S.M., Hunt, S.F., Ingall, A.H., Mckechnie, K.C.W., Ijzerman, A.P. & Leff, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475481.
  • Cusack, N.J. (1993). P2-receptor: subclassification and structure-activity relationships. Drug Dev. Res., 28, 244252.
  • Evans, R.J., Lewis, C., Buell, G., Valera, S., North, R.A. & Surprenant, A. (1995). Pharmacological characterisation of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol., 48, 178183.
  • Fleming, W.W., Westfall, D.P., De La Lande, I.S. & Jellett, L.B. (1972). Log-normal distribution of equi-effective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther., 181, 339345.
  • Flodgaard, H. & Klenow, H. (1982). Abundant amounts of diadenosine 5′,5′-P1, P4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets. Biol. J., 208, 737742.
  • Hashimoto & Kokubun (1995). Contribution of P2-purinoceptors to neurogenic contraction of rat urinary bladder smooth muscle. Br. J. Pharmacol., 115, 636640.
  • Hilderman, R.H., Martin, M., Zimmerman, J.K. & Pivorun, E.B. (1991). Identification of a unique membrane receptor for adenosine 5′,5′-P1, P4-tetraphosphate. J. Biol. Chem., 266, 69156918.
  • Hoyle, C.H.V., Knight, G.E. & Burnstock, G. (1990). Suramin antagonises responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br. J. Pharmacol., 99, 617621.
  • Hoyle, C.H.V., Postorino, A. & Burnstock, G. (1995a). Pre- and postjunctional effects of diadenosine polyphosphates in the guinea-pig vas deferens. J. Pharm. Pharmacol., 47, 926931.
  • Hoyle, C.H.V., Ziganshin, A.U. & Burnstock, G. (1995b). Diadenosine polyphosphates differentially activate P2X- and P2Y-purinoceptors in the guinea-pig urogenital and gastrointestinal tracts. Br. J. Pharmacol., 114, 107P.
  • Hoyle, C.H.V., Ziganshin, A.U., Pintor, J. & Burnstock, G. (1996). The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates. Br. J. Pharmacol., 118, 12941300.
  • Klishin, A., Lozovaya, N., Pintor, J., Miras-Portugal, M.T. & Krishtal, O. (1994). Possible functional role of diadenosine polyphosphates: negative feedback for excitation in hippocampus. Neuroscience, 58, 235236.
  • Lambrecht, G., Friebe, T., Grimm, U., Windscheif, U., Bungardt, E., Hildebrandt, C., Bäumert, H.G., Spatzkumbel, G. & Mütschler, E. (1992). PPADS, a novel functionally selective antagonist of P2-purinoceptor-mediated responses. Eur. J. Pharmacol., 217, 217219.
  • Lazarowski, E.R., Watt, W.C., Stutts, M.J., Boucher, R.C. & Harden, T.K. (1995). Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol., 116, 16191627.
  • Leff, P., Wood, B.E. & O'Connor, S.E. (1990). Suramin is a slowly-equilibrating but competitive antagonist at P2X-purinoceptors in the rabbit isolated ear artery. Br. J. Pharmacol., 101, 645649.
  • Mackenzie, I., Kirkpatrick, K.A. & Burnstock, G. (1988). Comparative study of the actions of AP5A and α,β-methyle-neATP on non-adrenergic, non-cholinergic neurogenic excitation in the guinea-pig vas deferens. Br. J. Pharmacol., 94, 699706.
  • Mclaren, G.J., Lambrecht, G., Mutschler, E., Bäumert, H.G., Sneddon, P. & Kennedy, C. (1994). Investigation of the actions of PPADS, a novel P2X-purinoceptor antagonist, in the guinea-pig isolated vas deferens. Br. J. Pharmacol., 111, 913917.
  • Nees, S. (1989). Coronary flow increases induced by adenosine and adenine nucleotides are mediated by the coronary endothelium: a new principle of the regulation of coronary flow. Eur. Heart J., 10, (Suppl. F), 2835.
  • Ogilvie, A. (1992). Extracellular functions for ApnA. In Ap4A and Other Dinucleotide Polyphosphates. ed. McLennan, A.G. pp. 229273.Boca Raton: CRC Press.
  • Pintor, J., Diaz-Rey, M.A. & Miras-Portugal, M.T. (1993). Ap4A and ADP-β-S binding to P2 purinoceptors present on rat brain synaptic terminals. Br. J. Pharmacol., 108, 10941099.
  • Pintor, J., Diaz-Rey, M.A., Torres, M. & Miras-Portugal, M.T. (1992). Presence of diadenosine polyphosphates -Ap4A and Ap5A- in rat brain synaptic terminals. Ca2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci. Lett., 136, 141144.
  • Pintor, J. & Miras-Portugal, M.T. (1995). A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes. Br. J. Pharmacol., 115, 895902.
  • Pintor, J., Torres, M. & Miras-Portugal, M.T. (1991). Carbachol induced release of diadenosine polyphosphates -Ap4A and Ap5A- from perfused bovine adrenal medulla and isolated chromaffin cells. Life Sci., 48, 23172324.
  • Pohl, U., Ogilvie, A., Lamontagne, D. & Busse, R. (1991). Potent effects of AP3A and AP4A on coronary resistance and autocoid release of intact rabbit hearts. Am. J. Physiol., 260, H1692H1697.
  • Ralevic, V., Hoyle, C.H.V. & Burnstock, G. (1995). Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. J. Physiol., 483, 703713.
  • Ramos, A., Pintor, J., Miras-Portugal, M.T. & Rotllan, P. (1995). Use of fluorogenic substrates for detection and investigation of ectoenzymatic hydrolysis of diadenosine polyphosphates: a fluorimetric study on chromaffin cells. Anal. Biochem., 228, 7482.
  • Rubino, A. & Burnstock, G. (1996). Possible role of diadenosine polyphosphates as modulators of cardiac sensory-motor neurotransmission in guinea-pigs. J. Physiol., 495, 515523.
  • Schlüter, H., Offers, E., Brüggemann, G., Van Der Glet, M., Tepel, T., Nordhoff, E., Karas, M., Spieker, C., Witzel, H. & Zidek, W. (1994). Diadenosine phosphates and the physiological control of blood pressure. Nature, 367, 186188.
  • Steinberg, T.H., Newman, A.S., Swanson, J.A. & Silverstein, S.C. (1987). ATP4- permeabilises the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem., 262, 88848888.
  • Stone, T.W. (1981). Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder. Eur. J. Pharmacol., 75, 93102.
  • Stone, T.W. & Paton, D.M. (1989). Possible subtypes of ATP receptor producing contraction of rat vas deferens, revealed by cross-desensitisation. Gen. Pharmacol., 20, 6164.
  • Tatham, P.E.R., Cusack, N.J. & Gomperts, B.D. (1988). Characterisation of the ATP4- receptor that mediates permeabilisation of rat mast cells. Eur. J. Pharmacol., 147, 1321.
  • Trezise, D.J., Bell, N.J., Khakh, B.S., Michel, A.D. & Humphrey, P.P.A. (1994). P2-purinoceptor antagonist properties of pyridoxal-5-phosphate. Eur. J. Pharmacol., 259, 295300.
  • Usune, S., Katsuragi, T. & Furukawa, T. (1996). Effects of PPADS and suramin on contractions and cytoplasmic Ca2+ changes evoked by AP4A, ATP and α,β-methyleneATP in guinea-pig urinary bladder. Br. J. Pharmacol., 117, 698702.
  • Walker, J., Bossman, P., Lackey, B.R., Zimmerman, J.K., Dimmick, M.A. & Hilderman, R.H. (1993). The adenosine 5′,5′-P1, P4-tetraphosphate receptor is at the cell surface of heart cells. Biochemistry, 32, 1400914014.
  • Westfall, T.D., Kennedy, C. & Sneddon, P. (1996a). Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br. J. Pharmacol., 117, 867872.
  • Westfall, T.D., Mcintyre, C.A., Obeid, S., Kennedy, C. & Sneddon, P. (1996b). Characterisation of P2X-purinoceptors in guinea-pig isolated vas deferens using agonists, antagonists and the ecto-ATPase inhibitor ARL 67156. Br. J. Pharmacol., 117, 104.
  • Ziganshin, A.U., Hoyle, C.H.V., Bo, X., Lambrecht, G., Mutschler, E., Bäumert, H.G. & Burnstock, G. (1993). PPADS selectively antagonises P2X-purinoceptor responses in the rabbit urinary bladder. Br. J. Pharmacol., 110, 14911495.
  • Ziganshin, A.U., Hoyle, C.H.V., Ziganshina, L.E. & Burnstock, G. (1995). Prejunctional inhibition of cholinergic neuromuscular transmission in the guinea-pig ileum by diadenosine polyphosphates. Br. J. Pharmacol., 114, 404P.